Literature DB >> 14643321

Design and synthesis of statine-containing BACE inhibitors.

Jingdan Hu1, Cynthia L Cwi, David L Smiley, David Timm, Jon A Erickson, James E McGee, Hsiu-Chiung Yang, David Mendel, Patrick C May, Mike Shapiro, James R McCarthy.   

Abstract

Utilizing structure-based techniques and solid-phase synthesis, statine-based tetrapeptide BACE inhibitors were designed and synthesized using a heptapeptide BACE transition-state mimetic, 1, as the starting point. Structure-activity relationship studies at the P(3), P(2), and P(2)' positions as well as the N-terminal capping group on scaffold 5 led to the discovery of potent inhibitors 27, 32, and 34 (IC(50) <100 nM). In addition, computational analysis and the X-ray structure of BACE-inhibitor 38 are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643321     DOI: 10.1016/j.bmcl.2003.09.037

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

2.  Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.

Authors:  Solveig Lefranc-Jullien; Vincent Lisowski; Jean-François Hernandez; Jean Martinez; Frédéric Checler
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 3.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

4.  Virtual screening and structure-based discovery of indole acylguanidines as potent β-secretase (BACE1) inhibitors.

Authors:  Yiquan Zou; Li Li; Wuyan Chen; Tiantian Chen; Lanping Ma; Xin Wang; Bing Xiong; Yechun Xu; Jingkang Shen
Journal:  Molecules       Date:  2013-05-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.